| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.003 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |